Additional Relevant Details Origent Data Sciences and Cytokinetics entered into a research collaboration to refine and prospectively validate an Origent computer model to predict the course of ALS disease progression leveraging data from Cytokinetics’ clinical trials of tirasemtiv.  Previously, the Origent models predicting both function and survival of ALS patients have been validated using internal and retrospective external datasets.